Home › Tokyo Institute Of Technology And Astellas Launch Collaborative Research For New Anti-Dengue Virus Drugs For Neglected Tropical Diseases
 

Keywords :   


Tokyo Institute Of Technology And Astellas Launch Collaborative Research For New Anti-Dengue Virus Drugs For Neglected Tropical Diseases

2013-03-21 04:09:00| drugdiscoveryonline News Articles

Tokyo Institute of Technology ("Tokyo Tech"; Tokyo, Japan; President: Yoshinao Mishima) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) recently announced that they have signed a joint research agreement for drug discovery research utilizing Tokyo Tech's TSUBAME2.0 supercomputer to efficiently discover candidates for the treatment of neglected tropical diseases ("NTDs") caused by dengue virus

Tags: research technology institute drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »